John B. Harlow Jr. insider trades

Open-market stock purchases and sales by John B. Harlow Jr., Chief Commercial Officer at Esperion Therapeutics, Inc, from SEC Form 4 filings since Dec 4, 2025.

Recent trades

DateStockTradeValue
Dec 4, 2025ESPR Esperion Therapeutics, IncBought (not open market)—
Dec 4, 2025ESPR Esperion Therapeutics, IncBought (not open market)—

Companies traded

  • ESPR Esperion Therapeutics, Inc: other filings, last Dec 4, 2025

Get free alerts when John B. Harlow Jr. files a new trade →